Answers are grounded in this paper and cite their sources.
Clinical guidance outlines individualized glucose-lowering options in type 2 diabetes mellitus, highlighting cellular mechanisms to optimize treatment.
Table 1dProperties of currently available glucose-lowering agents that may guide treatment choice in individual patients with type 2 diabetes mellitus Class Compound(s) Cellular mechanism
No takes yet. Share an insight, caveat, or question.
Inzucchi et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: